AngioDynamics, Inc. (ANGO)

Market Cap	367.33M
Revenue (ttm)	292.50M
Net Income (ttm)	-33.99M
Shares Out	40.63M
EPS (ttm)	-0.83
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	406,574
Open	8.69
Previous Close	8.69
Day's Range	8.64 - 9.09
52-Week Range	5.83 - 13.50
Beta	0.60
Analysts	Strong Buy
Price Target	19.00 (+110.18%)
Earnings Date	Jul 15, 2025

About ANGO

AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that is designed to deliver an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company’s thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mec...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: May 27, 2004
• Employees: 748
• Stock Exchange: NASDAQ
• Ticker Symbol: ANGO
• Website: https://www.angiodynamics.com

Financial Performance

In 2025, AngioDynamics's revenue was $292.50 million, a decrease of -3.76% compared to the previous year's $303.91 million. Losses were -$33.99 million, -81.56% less than in 2024.

Analyst Summary

According to 3 analysts, the average rating for ANGO stock is "Strong Buy." The 12-month stock price target is $19.0, which is an increase of 110.18% from the latest price.

Price Target

$19.0

(110.18% upside)

Analyst Consensus: Strong Buy